Results from the study, which focused on gynecological malignant tumors, were presented at the Society for Immunotherapy of ...
Germany’s Bayer saw its shares tumble almost 11% to 21.76 euros this morning, as it reported level third-quarter 2024 sales ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback